This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Astrazeneca Ab. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2017
Title: David Yunzhi Li: Innovator in Cancer Treatment
Introduction
David Yunzhi Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-cancer treatments. With a total of 3 patents, his work focuses on innovative compounds that target specific mutations in cancer cells.
Latest Patents
One of David's latest patents involves quinazoline inhibitors of activating mutant forms of the epidermal growth factor receptor (EGFR). This invention relates to compounds that possess inhibitory activity against these mutant forms of EGFR, which are crucial in the treatment of various cancers. The compounds, or their pharmaceutically acceptable salts, are designed to be effective in methods of treatment for both humans and animals. Additionally, the patent covers processes for manufacturing these compounds, pharmaceutical compositions containing them, and their use in creating medicaments aimed at producing an anti-cancer effect in warm-blooded animals, including humans.
Career Highlights
David Yunzhi Li is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His role involves extensive research and development in the field of oncology, where he applies his expertise to create innovative solutions for cancer treatment. His work has been instrumental in advancing therapeutic options for patients suffering from various forms of cancer.
Collaborations
David has collaborated with notable colleagues such as Jiabing Wang and Zhenfan Yang. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking innovations in cancer therapies.
Conclusion
David Yunzhi Li's contributions to the field of cancer treatment through his innovative patents and collaborations highlight his commitment to improving patient outcomes. His work continues to pave the way for advancements in pharmaceutical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile